Filter
614
Text search:
Mild
COVID
Featured
Recommendations
106
New Publications
2
Language
Document type
Guidelines
245
Studies & Reports
125
Fact sheets
85
Manuals
51
Strategic & Response Plan
38
Situation Updates
22
Training Material
15
Infographics
10
Brochures
7
Resource Platforms
6
Videos
4
Online Courses
3
No document type
3
Countries / Regions
Global
31
India
28
South Africa
25
Germany
24
Syria
22
Western and Central Europe
22
Latin America and the Carribbean
21
Middle East and North Africa
18
Russia
18
Brazil
17
East and Southern Africa
15
West and Central Africa
15
Africa
15
Eastern Europe and Central Asia
14
Kenya
11
South–East Asia Region
10
South Sudan
9
Yemen
9
Bangladesh
6
Mozambique
6
Nigeria
5
Angola
5
Western Pacific Region
5
Vietnam
5
Jordan
4
Eastern Europe
4
United Kingdom
4
Guinea-Bissau
3
Ethiopia
3
Ghana
3
Philippines
3
Lebanon
3
China
3
Malawi
3
Ukraine
3
Chile
3
Paraguay
3
Palestine
3
Tajikistan
3
Burkina Faso
2
Congo, Democratic Republic of
2
Côte d’Ivoire / Ivory Coast
2
Zimbabwe
2
Nepal
2
Pakistan
2
Iraq
2
Afghanistan
2
Turkey
2
Cambodia
2
Colombia
2
Ecuador
2
Laos
2
Kazakhstan
2
Portugal
2
Liberia
1
Mali
1
Saudi Arabia
1
Uganda
1
Somalia
1
Egypt
1
Chad
1
Thailand
1
Rwanda
1
Singapore
1
Sudan
1
Benin
1
Argentina
1
Peru
1
Eswatini/ Swaziland
1
North Macedonia
1
Austria
1
Switzerland
1
Serbia
1
Bolivia
1
Myanmar / Burma
1
Sri Lanka
1
Asia
1
Fiji
1
Venezuela
1
Armenia
1
Congo-Brazzaville
1
Moldova
1
Uzbekistan
1
Kyrgyzstan
1
Australia
1
Georgia
1
North America
1
France
1
Spain
1
South Korea
1
Authors & Publishers
Publication Years
Category
Countries
265
Clinical Guidelines
34
Public Health
25
Women & Child Health
19
Key Resources
12
Capacity Building
9
Pharmacy & Technologies
5
Toolboxes
COVID-19
458
NCDs
19
Rapid Response
13
Refugee
11
Conflict
10
Mental Health
9
Planetary Health
9
TB
8
Caregiver
8
HIV
7
NTDs
6
Disability
5
Pharmacy
5
AMR
4
Natural Hazards
3
Health Financing Toolbox
3
Ebola
1
Cholera
1
Zika
1
This document simplifies the WHO guidance on severe acute respiratory infection (SARI) treatment centres and is meant to be accessible to healthcare workers, policymakers and others who want
a quick overview of the key requirements for a COVID-19 i
...
Results of rapid assessment
The COVID-19 pandemic has disrupted or halted critical mental health services in 93% of countries worldwide while the demand for mental health is increasing, according to a new WHO survey. The survey of 130 countries pro
...
This article was published on December 10, 2020, and updated on December 16, 2020, at NEJM.org. DOI: 10.1056/NEJMoa2034577
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary include
...
9 September 2020
In a snapshot, fair allocation of vaccines will occur in the following way:
An initial proportional allocation of doses to countries until all countries reach enough quantities to cover 20% of their population
This document is also available in Arabic | Chinese | French | R
...
This brief summarizes current evidence and guidance for maintaining safe and effective care across the spectrum of maternal, newborn and infant care while protecting mother and child and health care providers during COVID-19. Furthermore, implicatio
...
Interim guidance, 12 August 2020This interim guidance has been updated with advice on safe and appropriate home care for patients with coronavirus disease 2019 (COVID-19) and on the public health measures related to the management of their contacts.
...
In 2020, the COVID-19 pandemic impacted the world beyond imagination. To date, it has infected more than 135 million people, killed over 2.9 million people, and is projected to plunge up to 115 million people into extreme poverty.1 As countries have
...
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an
...
Poster, 4 Janaury 2022
scientific brief, 2 March 2022
– (Comirnaty® 10 мкг або 30 мкг виробництва BioNTech/Pfizer та
AUFKLÄRUNGSMERKBLATT
Zur Schutzimpfung gegen COVID-19 (Corona Virus Disease 2019) (Grundimmunisierung und Auffrischimpfungen)
– mit mRNA-Impfstoffen –
...
ІНФОРМАЦІЙНИЙ ЛИСТ Для вакцинації проти COVID-19 (коронавірусне захворювання 2019 р.) (Первинна вакцинація)
recommended
– з вакциною на білковій основі
(Nuvaxovid® виробництва Novavax)
Станом на: 15 лютого 2022 р. (даний інформаційний лист постійно оновлюється)
AUFKLÄRUNGSMERKBLATT
Zur Schutzimpfung gegen
...
The World Health Organization (WHO) recognizes the challenges countries face for maintaining their COVID-19 response while addressing competing public health challenges, conflicts, climate change and economic crises. WHO continues to support countri
...
This guide is available in English, French, Spanish, Russian, Arabic and Chinese
This guide consolidates COVID-19 guidance for human resources for health managers and policy-makers at national, subnational and facility levels to design, manage and
...
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
